TNF-α antagonist attenuates systemic lipopolysaccharide-induced brain white matter injury in neonatal rats
Abstract Background Systemic inflammation is an important risk factor for neurodevelopmental impairments in preterm infants. Premyelinating oligodendrocytes are main building blocks of white matter in preterm infants and vulnerable to oxidative stress and excitotoxic stress. Tumour necrosis factor-α...
Main Authors: | Seung Han Shin, Ee-Kyung Kim, Kyung-yup Lee, Han-Suk Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | BMC Neuroscience |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12868-019-0529-1 |
Similar Items
-
Case Report: TNFα Antagonists Are an Effective Therapy in Cardiac Sarcoidosis
by: Julien Stievenart, et al.
Published: (2021-06-01) -
Coexistence of Ankylosing Spondylitis and Multiple Sclerosis: Trigger with TNF-alpha Antagonist Therapy or Coincidental?
by: Bahar Say, et al.
Published: (2019-09-01) -
Timing of sepsis is an important risk factor for white matter abnormality in extremely premature infants with sepsis
by: Ju Sun Heo, et al.
Published: (2018-02-01) -
Parental age effects on neonatal white matter development
by: Oliver Gale-Grant, et al.
Published: (2020-01-01) -
Role of interferon-gamma release assays (IGRAs) for the screening of latent tuberculosis infection in patients candidates for TNF-α antagonist
by: Ilaria Sauzullo, et al.
Published: (2010-06-01)